Wealth Enhancement Advisory Services
EDIT icon

Wealth Enhancement Advisory Services’s Editas Medicine EDIT Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
92,094
+3,725
+4% +$10.9K ﹤0.01% 3202
2026
Q1 		$236K Buy
88,369
+39,517
+81% +$83.6K ﹤0.01% 2997
2025
Q4 		$105K Sell
48,852
-2,062
-4% -$5.95K ﹤0.01% 3420
2025
Q3 		$200K Sell
50,914
-191
-0.4% -$533 ﹤0.01% 3143
2025
Q2 		$131K Buy
51,105
+6,088
+14% +$9.96K ﹤0.01% 3089
2025
Q1 		$52.2K Buy
45,017
+26,601
+144% +$39.1K ﹤0.01% 2843
2024
Q4 		$23.4K Buy
+18,416
New +$46.9K ﹤0.01% 2896

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Wealth Enhancement Advisory Services's EDIT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Editas Medicine (EDIT) stake by 4.2% in Q2 2026, buying an estimated $10.9K and bringing the position to 92,094 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #3202.

Wealth Enhancement Advisory Services first reported a position in EDIT in Q4 2024 and has held it in 7 quarters since. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Wealth Enhancement Advisory Services held 92,094 shares of Editas Medicine worth $300K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 3,725 Editas Medicine shares in Q2 2026, an estimated $10.9K.
  • Editas Medicine made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3202 holding.
  • Wealth Enhancement Advisory Services first reported a position in Editas Medicine in Q4 2024 and has held it in 7 quarters since.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.